Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1Endocrine 1

Conditions

Gastrointestinal Neoplasms 1Carcinoma, Neuroendocrine 1

Interventions

Cisplatin 3trametinib 1repotrectinib 1pralsetinib 1lutetium Lu 177 dotatate 1lanreotide 1dabrafenib 1copper dotatate CU-64 1alectinib 1Surveys and Questionnaires 1Referral and Consultation 1Quality of Life 1Poly(ADP-ribose) Polymerase Inhibitors 1Nivolumab 1Neoadjuvant Therapy 1Microscopy, Electron 1Lutetium-177 1Lutetium 1Irinotecan 1Ipilimumab 1Etoposide 1Cytoreduction Surgical Procedures 1Cryotherapy 1Carboplatin 1CYT-6091 1Aromatherapy 1Acupuncture Therapy 1Acupressure 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Gastrointestinal Neoplasms × Neoadjuvant Therapy × Endocrine × Clear all
NCT04268121 2025-07-23

NEONEC

GERCOR - Multidisciplinary Oncology Cooperative Group

Phase 2 Recruiting
78 enrolled
EndocrineGastrointestinal

Gastrointestinal Neoplasms, Carcinoma, Neuroendocrine

Data powered by HemOnc (CC BY 4.0) Colophon âš¡